CGCN GROUP, LLC for EMERGENT BIOSOLUTIONS INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; State opioid response (SOR) Grant funding for FY24 and FY25; Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25; NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone; HANDS Act - H.R. 5506; SAVE Act of 2023 - H.R. 6161; Overdose Reversal Medication (ORM) Act - H.R. 6243; Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVE CLARK | — |
| JAY CRANFORD | — |
| SAM GEDULDIG | — |
| SUSAN GRIFFITHS | — |
| JILL HAMAKER | — |
| AMBER KIRCHHOEFER | — |
| MARTHA BEATRICE MILLER | — |
| MIKE NIELSEN | — |
| ALEX RENJEL | — |
| SCOTT RIPLINGER | — |
| JA'RON SMITH New | — |
| JOHN STIPICEVIC | — |
Disaster Planning/Emergencies DIS
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; State opioid response (SOR) Grant funding for FY24 and FY25; Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25; NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone; HANDS Act - H.R. 5506; SAVE Act of 2023 - H.R. 6161; Overdose Reversal Medication (ORM) Act - H.R. 6243; Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVE CLARK | — |
| JAY CRANFORD | — |
| SAM GEDULDIG | — |
| SUSAN GRIFFITHS | — |
| JILL HAMAKER | — |
| AMBER KIRCHHOEFER | — |
| MARTHA BEATRICE MILLER | — |
| MIKE NIELSEN | — |
| ALEX RENJEL | — |
| SCOTT RIPLINGER | — |
| JA'RON SMITH New | — |
| JOHN STIPICEVIC | — |
Health Issues HCR
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; State opioid response (SOR) Grant funding for FY24 and FY25; Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25; NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone; HANDS Act - H.R. 5506; SAVE Act of 2023 - H.R. 6161; Overdose Reversal Medication (ORM) Act - H.R. 6243; Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVE CLARK | — |
| JAY CRANFORD | — |
| SAM GEDULDIG | — |
| SUSAN GRIFFITHS | — |
| JILL HAMAKER | — |
| AMBER KIRCHHOEFER | — |
| MARTHA BEATRICE MILLER | — |
| MIKE NIELSEN | — |
| ALEX RENJEL | — |
| SCOTT RIPLINGER | — |
| JA'RON SMITH New | — |
| JOHN STIPICEVIC | — |
Homeland Security HOM
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; State opioid response (SOR) Grant funding for FY24 and FY25; Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25; NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone; HANDS Act - H.R. 5506; SAVE Act of 2023 - H.R. 6161; Overdose Reversal Medication (ORM) Act - H.R. 6243; Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVE CLARK | — |
| JAY CRANFORD | — |
| SAM GEDULDIG | — |
| SUSAN GRIFFITHS | — |
| JILL HAMAKER | — |
| AMBER KIRCHHOEFER | — |
| MARTHA BEATRICE MILLER | — |
| MIKE NIELSEN | — |
| ALEX RENJEL | — |
| SCOTT RIPLINGER | — |
| JA'RON SMITH New | — |
| JOHN STIPICEVIC | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.